日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cystatin C Confirms the Canagliflozin eGFR Slope Benefit in CANPIONE

胱抑素C证实了CANPIONE研究中卡格列净对eGFR斜率的改善作用

Miyamoto, Satoshi; Heerspink, Hiddo J L; de Zeeuw, Dick; Sakamoto, Kota; Yoshida, Michihiro; Toyoda, Masao; Suzuki, Daisuke; Hatanaka, Takashi; Nakamura, Tohru; Kamei, Shinji; Murao, Satoshi; Hida, Kazuyuki; Ando, Shinichiro; Akai, Hiroaki; Takahashi, Yasushi; Kitada, Munehiro; Sugano, Hisashi; Nunoue, Tomokazu; Nakamura, Akihiko; Sasaki, Motofumi; Nakatou, Tatsuaki; Fujimoto, Kei; Kawanami, Daiji; Wada, Takashi; Miyatake, Nobuyuki; Kuramoto, Hiromi; Shikata, Kenichi

Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3)

血浆血管紧张素转换酶 2 (ACE2) 是糖尿病肾病 (DKD) 肾脏结局的标志物(U-CARE 研究 3)

Ueno, Asami; Onishi, Yasuhiro; Mise, Koki; Yamaguchi, Satoshi; Kanno, Ayaka; Nojima, Ichiro; Higuchi, Chigusa; Uchida, Haruhito A; Shikata, Kenichi; Miyamoto, Satoshi; Nakatsuka, Atsuko; Eguchi, Jun; Hida, Kazuyuki; Katayama, Akihiro; Watanabe, Mayu; Nakato, Tatsuaki; Tone, Atsuhito; Teshigawara, Sanae; Matsuoka, Takashi; Kamei, Shinji; Murakami, Kazutoshi; Shimizu, Ikki; Miyashita, Katsuhito; Ando, Shinichiro; Nunoue, Tomokazu; Wada, Jun

The Change in Public Perception and Knowledge Acquisition Methods of Chronic Kidney Disease Among General Population in Okayama Prefecture, Japan

日本冈山县普通人群对慢性肾脏病的认知和知识获取方式的变化

Umebayashi, Ryoko; Matsuoka-Uchiyama, Natsumi; Sugiyama, Hitoshi; Shikata, Kenichi; Kashihara, Naoki; Makino, Hirofumi; Wada, Jun; Uchida, Haruhito A

Suramin prevents the development of diabetic kidney disease by inhibiting NLRP3 inflammasome activation in KK-Ay mice

苏拉明通过抑制KK-Ay小鼠体内NLRP3炎症小体的激活来预防糖尿病肾病的发生。

Oda, Kaori; Miyamoto, Satoshi; Kodera, Ryo; Wada, Jun; Shikata, Kenichi

Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study

CANPIONE 研究:卡格列净治疗日本人群中 2 型糖尿病合并微量白蛋白尿患者的疗效研究原理、设计和基线特征

Miyamoto, Satoshi; Heerspink, Hiddo J L; de Zeeuw, Dick; Toyoda, Masao; Suzuki, Daisuke; Hatanaka, Takashi; Nakamura, Tohru; Kamei, Shinji; Murao, Satoshi; Hida, Kazuyuki; Ando, Shinichiro; Akai, Hiroaki; Takahashi, Yasushi; Koya, Daisuke; Kitada, Munehiro; Sugano, Hisashi; Nunoue, Tomokazu; Nakamura, Akihiko; Sasaki, Motofumi; Nakatou, Tatsuaki; Fujimoto, Kei; Kawanami, Daiji; Wada, Takashi; Miyatake, Nobuyuki; Yoshida, Michihiro; Shikata, Kenichi

The Association of Postprandial Triglyceride Variability with Renal Dysfunction and Microalbuminuria in Patients with Type 2 Diabetic Mellitus: A Retrospective and Observational Study

餐后甘油三酯变异与2型糖尿病患者肾功能障碍和微量白蛋白尿的相关性:一项回顾性观察研究

Matsuoka-Uchiyama, Natsumi; Uchida, Haruhito A; Okamoto, Shugo; Onishi, Yasuhiro; Katayama, Katsuyoshi; Tsuchida-Nishiwaki, Mariko; Takeuchi, Hidemi; Takemoto, Rika; Hada, Yoshiko; Umebayashi, Ryoko; Kurooka, Naoko; Tsuji, Kenji; Eguchi, Jun; Nakajima, Hirofumi; Shikata, Kenichi; Wada, Jun

Reduction in the magnitude of serum potassium elevation in combination therapy with esaxerenone (CS-3150) and sodium-glucose cotransporter 2 inhibitor in patients with diabetic kidney disease: Subanalysis of two phase III studies

在糖尿病肾病患者中,依沙克雷酮 (CS-3150) 与钠-葡萄糖协同转运蛋白 2 抑制剂联合治疗可降低血清钾升高的程度:两项 III 期研究的亚组分析

Shikata, Kenichi; Ito, Sadayoshi; Kashihara, Naoki; Nangaku, Masaomi; Wada, Takashi; Okuda, Yasuyuki; Sawanobori, Tomoko; Sugimoto, Kotaro

Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry)

阿格列汀(一种 DPP-4 抑制剂)在 2 型糖尿病患者中的长期安全性和有效性:一项为期 3 年的前瞻性、对照、观察性研究(J-BRAND 注册研究)

Ueki, Kohjiro; Tanizawa, Yukio; Nakamura, Jiro; Yamada, Yuichiro; Inagaki, Nobuya; Watada, Hirotaka; Shimomura, Iichiro; Nishimura, Rimei; Miyoshi, Hideaki; Abiko, Atsuko; Katagiri, Hideki; Hayashi, Michio; Shimada, Akira; Naruse, Keiko; Fujimoto, Shimpei; Fujiwara, Masazumi; Shikata, Kenichi; Okada, Yosuke; Araki, Eiichi; Yamazaki, Tsutomu; Kadowaki, Takashi

Randomized trial of an intensified, multifactorial intervention in patients with advanced-stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan)

针对晚期糖尿病肾病患者的强化多因素干预的随机试验:日本糖尿病肾病缓解和消退团队试验(DNETT-Japan)

Shikata, Kenichi; Haneda, Masakazu; Ninomiya, Toshiharu; Koya, Daisuke; Suzuki, Yoshiki; Suzuki, Daisuke; Ishida, Hitoshi; Akai, Hiroaki; Tomino, Yasuhiko; Uzu, Takashi; Nishimura, Motonobu; Maeda, Shiro; Ogawa, Daisuke; Miyamoto, Satoshi; Makino, Hirofumi

Recent evidence in the etiology and treatment for diabetic kidney disease

糖尿病肾病病因和治疗方面的最新证据

Shikata, Kenichi